Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial
CONCLUSIONSAlthough our primary outcome was not statistically significant, the tested approach deserves further study with further optimization of its components.
Source: Diabetes Care - Category: Endocrinology Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Insulin | Janumet | Januvia | Lantus | Metformin | Statistics | Study